HAL (France)open access
CD39, nouvelle cible thérapeutique dans les lymphomes non Hodgkiniens - mythe ou réalité ?
Targeted immunotherapy, Lymphocytes T gamma delta, 1, Non-Hodgkin's lymphoma, Gamma delta T cells, Mécanismes d'immunoéchappement, Immunothérapie ciblée, Lymphomes non-Hodgkiniens
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226839
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.